#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial encephalomyopathy Acquired C1 inhibitor deficiency Mastocytosis Neuromyelitis optica spectrum disorder Chronic lymphocytic leukaemia Thalassaemia alpha Gastric cancer Congenital absence of bile ducts Neurodevelopmental disorder Chronic hepatitis B Leiomyosarcoma metastatic Malignant glioma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Central nervous system neoplasm Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Familial amyotrophic lateral sclerosis – Diagnostics Behcet’s syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Treatment Acute respiratory distress syndrome Rhabdomyosarcoma – Diagnostics Leiomyosarcoma – Trials in Disease Mantle cell lymphoma – Life with Disease Myelodysplastic syndrome with excess blasts – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease Sjogren’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pegcetacoplan Ptc518 Sitravatinib Malate Befiradol (18F) Fremanezumab Mitomycin 11902A Carbetocin Avacincaptad Pegol PEGVISOMANT Anhydrous Caffeine Iberdomide Lovastatin ZUNIBERGENE ROCPARVOVEC Anselamimab Midazolam Tpst-1120 Bedaquiline Selgantolimod Rezpegaldesleukin More therapies…

    Learn about Your Condition

    Bronchopulmonary dysplasia Myositis Hyperthyroidism Antisynthetase syndrome Immune-mediated enterocolitis Nasopharyngeal cancer Colitis Proteus syndrome Dyslipidaemia Oesophageal carcinoma Diarrhoea Bacteraemia Hypersensitivity Marginal zone lymphoma Narcolepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic retinal oedema

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Macular oedema
    Investigated Drugs:
    • Eye103
    • Ranibizumab
    • Fluorescein Sodium
    Austria Croatia Czechia France Germany Hungary +6
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!